Elorexa comprises Eflornithine, classified within the category of medications known as Ornithine decarboxylase inhibitors. It is utilized in the treatment of facial hirsutism in females. Facial hirsutism is a condition characterized by undesirable excessive hair development on the chin, mouth, and other facial regions in women, often distributed in a pattern akin to that of males,...